Regulus HCV Candidate On Clinical Hold After Second Jaundice Report
This article was originally published in The Pink Sheet Daily
Executive Summary
First jaundice adverse event was deemed unlikely to be connected to treatment with RG-101, and the second patient presents similar profile of overall health and co-morbidities.